In silico strategies to describe the formation of the inclusion complex between β-cyclodextrin and β-naphtyloxyacetic acid: A preliminary step towards prediction of log K

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 57, Issue 1-4, 2007, Pages 355-361

  Ermondi, Giuseppe ^a   Cillis, Giovanni Ivan ^a   Caron, Giulia ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Cyclodextrin; Naphtyloxyacetic acid; Docking; In silico; Inclusion complexes

Indexed keywords

EID: 34047232759     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-006-9258-z     Document Type: Conference Paper

References (27)

1. Van de Waterbeemd, H., Smith, D.A., Beaumont, K., Walker, D.K.: Property-based design: optimization of drug absorption and pharmacokinetics. J. Med. Chem. 44, 1313-1333 (2001)
2. Davis, M.E., Brewster, M.E.: Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3, 1023-1035 (2004)
3. Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 1743-1753 (1998)
4. Stella, V.J., Rajewski, R.A.: Cyclodextrins: their future in drug formulation and delivery. Pharm. Res. 14, 556-567 (1997)
5. Thompson, D.O.: Cyclodextrins-enabling excipients: their present and future use in pharmaceuticals. Crit. Rev. Ther. Drug Carr. Syst. 14, 1-104 (1997)
6. Lichtenthaler, F.W., Immel, S.: On the hydrophobic characteristics of cyclodextrins: computer-aided visualization of molecular lipophilicity patterns. Liebigs Ann. 27-37 (1996)
7. Uccello-Barretta, G., Balzano, F., Paolino, D., Ciaccio, R., Guccione, S.: Combined NMR-crystallographic and modelling investigation of the inclusion of molsidomine into α-, β-, and γ-cyclodextrins. Bioorg. Med. Chem. 13, 6502-6512 (2005)
8. Halperin, I., Ma, B., Wolfon, H., Nussinov, R.: Principles of docking: an overview of search algorithms and a guide to scoring functions. Protein Struct. Funct. Genet. 47, 409-443 (2002)
9. Mercury, version 1.3., 2005, CCDC, Cambridge, UK, http://www.ccdc.cam.ac. uk/products/csd_system/mercury
10. MOE, version 2005.06,. 2005,. Chemical Computing Group, Montreal, Quebec Canada, http://www.chemcomp.com/
11. Qiu, D., Shenkin, P.S., Hollinger, F.P., Still, W.C.: The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate born radii. J. Phys. Chem. A 101, 3005-3014 (1997)
12. Caron, G., Ermondi, G., Damiano, A., Novaroli, L., Tsinman, O., Ruell, J. A., Avdeef, A.: Ionization, lipophilicity, and molecular modeling to investigate permeability and other biological properties of amlodipine. Bioorg. Med. Chem. 12, 6107-6118 (2004)
13. Goodford, P.J.: A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 28, 849-857 (1985)
14. Wade, R.C., Clark, K.J., Goodford, P.J.: Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 1. Ligand probe groups with the ability to form two hydrogen bonds. J. Med. Chem. 36, 140-147 (1993)
15. Wade, R.C., Goodford, P.J.: Further development of hydrogen bond functions for use in determining energetically favorable binding sites on molecules of known structure. 2. Ligand probe groups with the ability to form more than two hydrogen bonds. J. Med. Chem. 36, 148-156 (1993)
16. GRID, version 22b, 2004, Molecular Discovery Ltd, West Way House, Elms Parade, Oxford, http://www.moldiscovery.com
17. Ermondi G., Anghilante C., Caron G.: A combined in silico strategy to describe the variation of some 3D molecular properties of β-cyclodextrin due to the formation of inclusion complexes. J. Mol. Graphics and Modelling 25, 296-303 (2006)
18. Ermondi, G., Caron, G., Longo, D.: Design of a systematic docking tool and application to COX isozymes/NSAIDs complexes. J. Comput. Aid. Mol. Des. 18, 683-696 (2004)
19. Houk, K.N., Leach, A.G., Kim, S., Zhang, X.: Binding affinities of host-guest, protein-ligand, and protein-transition-state complexes. Angew. Chem. Int. Ed. 42, 4872-4897 (2003)
20. Kokkinou, A., Yannakopoulou, K., Mavridis, I.M., Mentzafos, D.: Structure of the complex of β-cyclodextrin with β-naphthyloxyacetic acid in the solid state and in aqueous solution. Carbohydrate Res. 332, 85-94 (2001)
21. Rekharsky, M.V., Inoue, Y.: Complexation thermodynamics of cyclodextrins. Chem. Rev. 98, 1875-1917 (1998)
22. Lipkowitz, K.B.: Applications of computational chemistry to the study of cyclodextrin. Chem. Rev. 98, 1829-1873 (1998)
23. Caron G., Ermondi G.: Variations in MIFs content of α- cyclodextrins, caused by the formation of inclusion complexes, enables the complexes to be classified as Type 1 and Type 2. J. Mol. Graph Model, (2006). doi:10.1016/j.jmgm.2006.06.003
24. Uccello-Barretta, G., Balzano, F., Sicoli, G., Friglola, C., Aldana, I., Monge, A., Paolino, D., Guccione, S.:Combining NMR and molecular modelling in a drug delivery context: investigation of the multi-mode inclusion of a new NPY-5 antagonist bromobenzenesulfonamide into β-cyclodextrin. Bioorg. Med. Chem. 12(2), 447-458 (2004)
25. Jara, F., Mascayano, C., Rezende, M.C., Tirapegui, C., Urzua, A.: A spectral and molecular dynamics simulation study of β-cyclodextrin inclusion complexes with solvatochromic dyes derived from barbituric acid. J. Incl. Phenom. Macroc. Chem. 54, 95-99 (2006)
26. Piel, G., Dive, G., Evrard, B., Van Hees, T., Henry de Hassonville, S., Delattre, L.: Molecular modeling study of b-and g-cyclodextrin complexes with miconazole. Eur. J. Pharm. Sci. 13, 271-279 (2001)
27. 1H NMR and ROESY experiments. Eur. J. Pharm. Sci. 18, 285-296 (2003)